Randomized Study of Yohimbine Treatment for Type 2 Diabetes Patients Carrying a Specific Genetic Risk Variant

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The investigators have recently discovered a genetic variant in an adrenergic receptor that leads to increased risk for type 2 diabetes. The investigators have also seen that blockers of that receptor improves impaired insulin secretion in animals. The investigators will now test the blocker in patients with type 2 diabetes with or without the risk variant in an effort to make diabetes treatment more individualized.
Epistemonikos ID: 7a3b77cce0a9697f354ee39ea953fb38baeed557
First added on: May 10, 2024